Khan Zahida, Yokota Shinichiro, Ono Yoshihiro, Bell Aaron W, Oertel Michael, Stolz Donna B, Michalopoulos George K
Gene Expr. 2017 Feb 10;17(2):115-127. doi: 10.3727/105221616X692991. Epub 2016 Aug 18.
α-1 Antitrypsin deficiency (A1ATD) can progress to cirrhosis and hepatocellular carcinoma; however, not all patients are susceptible to severe liver disease. In A1ATD, a toxic gain-of-function mutation generates insoluble ATZ "globules" in hepatocytes, overwhelming protein clearance mechanisms. The relationship between bile acids and hepatocytic autophagy is less clear but may involve altered gene expression pathways. Based on previous findings that bile duct ligation (BDL) induces autophagy, we hypothesized that retained bile acids may have hepatoprotective effects in PiZZ transgenic mice, which model A1ATD. We performed BDL and partial BDL (pBDL) in PiZZ mice, followed by analysis of liver tissues. PiZZ liver subjected to BDL showed up to 50% clearance of ATZ globules, with increased expression of autophagy proteins. Analysis of transcription factors revealed significant changes. Surprisingly nuclear TFEB, a master regulator of autophagy, remained unchanged. pBDL confirmed that ATZ globule clearance was induced by localized stimuli rather than diet or systemic effects. Several genes involved in bile metabolism were overexpressed in globule-devoid hepatocytes, compared to globule-containing cells. Retained bile acids led to a dramatic reduction of ATZ globules, with enhanced hepatocyte regeneration and autophagy. These findings support investigation of synthetic bile acids as potential autophagy-enhancing agents.
α-1抗胰蛋白酶缺乏症(A1ATD)可进展为肝硬化和肝细胞癌;然而,并非所有患者都易患严重肝病。在A1ATD中,一种功能获得性毒性突变在肝细胞中产生不溶性的ATZ“小球”,使蛋白质清除机制不堪重负。胆汁酸与肝细胞自噬之间的关系尚不清楚,但可能涉及基因表达途径的改变。基于先前胆管结扎(BDL)诱导自噬的研究结果,我们推测潴留的胆汁酸可能对PiZZ转基因小鼠具有肝脏保护作用,该小鼠可模拟A1ATD。我们对PiZZ小鼠进行了BDL和部分BDL(pBDL),随后对肝脏组织进行分析。接受BDL的PiZZ肝脏显示ATZ小球清除率高达50%,自噬蛋白表达增加。转录因子分析显示有显著变化。令人惊讶的是,自噬的主要调节因子核内TFEB没有变化。pBDL证实ATZ小球清除是由局部刺激而非饮食或全身效应诱导的。与含小球的细胞相比,参与胆汁代谢的几个基因在无小球的肝细胞中过表达。潴留的胆汁酸导致ATZ小球显著减少,肝细胞再生和自噬增强。这些发现支持将合成胆汁酸作为潜在的自噬增强剂进行研究。